🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

165 results for “Sunshine Biopharma” Clear

  1. PEGylated recombinant candida urate oxidase

    Sunshine Biopharma

    Gout

    phase 1 small molecule active

    1 trial
  2. Pegylated Recombinant Candida Utilis Uricase for Injection

    Sunshine Biopharma

    Gout

    phase 1 small molecule active

    1 trial
  3. Placebo

    Sunshine Biopharma

    Healthy

    phase 1 small molecule completed

    1 trial
  4. Recombinant erythropoietin stimulating protein

    Sunshine Biopharma

    Chronic Renal Failure

    phase 1 small molecule active

    1 trial
  5. Recombinant human thrombopoietin

    Sunshine Biopharma

    Liver Cirrhosis

    phase 1 small molecule active

    1 trial
  6. Rongliflozin

    Sunshine Biopharma

    Type 2 Diabetes Mellitus

    phase 1 small molecule completed

    1 trial
  7. SPGL008

    Sunshine Biopharma

    Advanced Malignant Tumors

    phase 1 small molecule active

    1 trial
  8. SSGJ-612

    Sunshine Biopharma

    Advanced Malignant Tumors

    phase 1 small molecule active

    1 trial
  9. SSGJ-613

    Sunshine Biopharma

    Systemic Juvenile Idiopathic Arthritis

    phase 1 small molecule active

    1 trial
  10. SSGJ-613

    Sunshine Biopharma

    Arthritis, Gouty

    phase 1 small molecule active

    1 trial
  11. SSGJ-705

    Sunshine Biopharma

    Receptor, ErbB-2

    phase 1 small molecule active

    1 trial
  12. SSGJ-706

    Sunshine Biopharma

    Advanced Solid Tumors Patients

    phase 1 small molecule active

    1 trial
  13. SSGJ-709

    Sunshine Biopharma

    Advanced Malignant Tumors

    phase 1 small molecule active

    1 trial
  14. SSS11

    Sunshine Biopharma

    Gout

    phase 1 mab active

    1 trial
  15. SSS17

    Sunshine Biopharma

    Anemia in Chronic Kidney Diseases

    phase 1 small molecule active

    2 trials
  16. SSS17

    Sunshine Biopharma

    Healthy Subjects (HS)

    phase 1 small molecule completed

    1 trial
  17. SSS39

    Sunshine Biopharma

    Safety and Tolerability in Healthy Volunteers

    phase 1 small molecule active

    1 trial
  18. SSS55

    Sunshine Biopharma

    Safety Issues

    phase 1 small molecule active

    1 trial
  19. SSS59

    Sunshine Biopharma

    Malignant Tumors

    phase 1 small molecule active

    1 trial
  20. SSS67 Injection

    Sunshine Biopharma

    Healthy

    phase 1 small molecule active

    1 trial
  21. Yimitasvir Phosphate

    Sunshine Biopharma

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial
  22. Yimitasvir Phosphate Capsule

    Sunshine Biopharma

    Renal Impairment

    phase 1 small molecule completed

    1 trial
  23. Z650

    Sunshine Biopharma

    Pancreatic Cancer

    phase 1 small molecule terminated

    1 trial
  24. [14C] Antaitavir Hasophate

    Sunshine Biopharma

    Healthy Male Subjects

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources